Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
AxoGen (AXGN)
NASDAQ:AXGN
AxoGen (AXGN) Stock Price & Analysis
365 Followers
AXGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.45 - $10.83
Previous Close$5.83
Volume65.96K
Average Volume (3M)362.02K
Market Cap
$264.41M
Enterprise Value$270.38M
Total Cash (Recent Filing)$31.02M
Total Debt (Recent Filing)$46.60M
Price to Earnings (P/E)-11.8
Beta1.32
Next Earnings
Aug 06, 2024EPS Estimate
-$0.05Last Dividend Ex-Date
Jan 27, 2010Dividend YieldN/A
Share Statistics
EPS (TTM)-0.49
Shares Outstanding43,704,574
10 Day Avg. Volume297,453
30 Day Avg. Volume362,016
Standard Deviation0.19
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)2.72
Price to Sales (P/S)1.60
Price to Cash Flow (P/CF)-293.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.70
Enterprise Value/Gross Profit2.11
Enterprise Value/Ebitda-21.74
Forecast
1Y Price Target
$15.50Price Target Upside156.20% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
AxoGen News
PremiumCompany Announcements
AxoGen Updates Corporate Presentation for Stakeholders
PremiumCompany Announcements
New Accounting & Financial Operations Risk for AxoGen – What’s the Latest?
Ownership Overview
33.09% Insiders
21.63% Mutual Funds
13.75% Other Institutional Investors
31.52% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AXGN FAQ
What was AxoGen’s price range in the past 12 months?
AxoGen lowest stock price was $3.45 and its highest was $10.83 in the past 12 months.
What is AxoGen’s market cap?
Currently, no data Available
When is AxoGen’s upcoming earnings report date?
AxoGen’s upcoming earnings report date is Aug 06, 2024 which is in 88 days.
How were AxoGen’s earnings last quarter?
AxoGen released its earnings results on May 02, 2024. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.068 by $0.008.
Is AxoGen overvalued?
According to Wall Street analysts AxoGen’s price is currently Undervalued.
Does AxoGen pay dividends?
AxoGen pays a Notavailable dividend of $1 which represents an annual dividend yield of N/A. See more information on AxoGen dividends here
What is AxoGen’s EPS estimate?
AxoGen’s EPS estimate is -$0.05.
How many shares outstanding does AxoGen have?
AxoGen has 43,704,575 shares outstanding.
What happened to AxoGen’s price movement after its last earnings report?
AxoGen reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.068. Following the earnings report the stock price went down -10.366%.
Which hedge fund is a major shareholder of AxoGen?
Among the largest hedge funds holding AxoGen’s share is Perceptive Advisors LLC. It holds AxoGen’s shares valued at 6M.
---
AxoGen Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.50 (156.20% Upside)
$15.50 (156.20% Upside)
Blogger Sentiment
Bullish
AXGN Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 82.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $544.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▼ 6.4%
Last 30 Days ▼ 6.4%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.11%
12-Months-Change
Fundamentals
Return on Equity
-22.32%
Trailing 12-Months
Asset Growth
-1.56%
Trailing 12-Months
Company Description
AxoGen
AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.
---
AXGN Earnings Call
Q1 2024
0:00 / 0:00
---
AXGN Stock 12 Month Forecast
Average Price Target
$15.50
▲(156.20% Upside)
Technical Analysis
Best Analysts Covering AXGN
1 Year
1 Year Success Rate
6/20 ratings generated profit
1 Year Average Return
+2.02%
reiterated a buy rating 2 months ago
Copying David Turkaly's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of +2.02% per trade.
---